173 related articles for article (PubMed ID: 24484292)
1. Effect of porcine circovirus type 2 (PCV2) vaccination on PCV2-viremic piglets after experimental PCV2 challenge.
Seo HW; Park C; Han K; Chae C
Vet Res; 2014 Feb; 45(1):13. PubMed ID: 24484292
[TBL] [Abstract][Full Text] [Related]
2. Impact of maternally derived immunity on piglets' immune response and protection against porcine circovirus type 2 (PCV2) after vaccination against PCV2 at different age.
Martelli P; Saleri R; Ferrarini G; De Angelis E; Cavalli V; Benetti M; Ferrari L; Canelli E; Bonilauri P; Arioli E; Caleffi A; Nathues H; Borghetti P
BMC Vet Res; 2016 May; 12():77. PubMed ID: 27170186
[TBL] [Abstract][Full Text] [Related]
3. A PCV2 vaccine based on genotype 2b is more effective than a 2a-based vaccine to protect against PCV2b or combined PCV2a/2b viremia in pigs with concurrent PCV2, PRRSV and PPV infection.
Opriessnig T; O'Neill K; Gerber PF; de Castro AM; Gimenéz-Lirola LG; Beach NM; Zhou L; Meng XJ; Wang C; Halbur PG
Vaccine; 2013 Jan; 31(3):487-94. PubMed ID: 23174198
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of a porcine circovirus type 2a (PCV2a) vaccine efficacy against experimental PCV2a, PCV2b, and PCV2d challenge.
Park KH; Oh T; Yang S; Cho H; Kang I; Chae C
Vet Microbiol; 2019 Apr; 231():87-92. PubMed ID: 30955830
[TBL] [Abstract][Full Text] [Related]
5. An experimental live chimeric porcine circovirus 1-2a vaccine decreases porcine circovirus 2b viremia when administered intramuscularly or orally in a porcine circovirus 2b and porcine reproductive and respiratory syndrome virus dual-challenge model.
Opriessnig T; Gomes-Neto JC; Hemann M; Shen HG; Beach NM; Huang Y; Halbur PG; Meng XJ
Microbiol Immunol; 2011 Dec; 55(12):863-73. PubMed ID: 21951266
[TBL] [Abstract][Full Text] [Related]
6. Fetal infections and antibody profiles in pigs naturally infected with porcine circovirus type 2 (PCV2).
Gerber PF; Garrocho FM; Lana AM; Lobato ZI
Can J Vet Res; 2012 Jan; 76(1):38-44. PubMed ID: 22754093
[TBL] [Abstract][Full Text] [Related]
7. Comparison of sow and/or piglet vaccination of 3 commercial porcine circovirus type 2 (PCV2) single-dose vaccines on pigs under experimental PCV2 challenge.
Oh Y; Seo HW; Park C; Chae C
Vet Microbiol; 2014 Aug; 172(3-4):371-80. PubMed ID: 24970364
[TBL] [Abstract][Full Text] [Related]
8. Effect of sow and piglet porcine circovirus type 2 (PCV2) vaccination on piglet mortality, viraemia, antibody titre and production parameters.
Fraile L; Sibila M; Nofrarías M; López-Jimenez R; Huerta E; Llorens A; López-Soria S; Pérez D; Segalés J
Vet Microbiol; 2012 Dec; 161(1-2):229-34. PubMed ID: 22858231
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of cell-mediated immune responses against porcine circovirus type 2 (PCV2) Cap and Rep proteins after vaccination with a commercial PCV2 sub-unit vaccine.
Fort M; Sibila M; Nofrarías M; Pérez-Martín E; Olvera A; Mateu E; Segalés J
Vet Immunol Immunopathol; 2012 Nov; 150(1-2):128-32. PubMed ID: 23010221
[TBL] [Abstract][Full Text] [Related]
10. A Porcine circovirus type 2b (PCV2b)-based experimental vaccine is effective in the PCV2b-Mycoplasma hyopneumoniae coinfection pig model.
Opriessnig T; Castro AMMG; Karuppanan AK; Gauger PC; Halbur PG; Matzinger SR; Meng XJ
Vaccine; 2019 Oct; 37(44):6688-6695. PubMed ID: 31537445
[TBL] [Abstract][Full Text] [Related]
11. Effect of vaccination of boars against porcine circovirus type 2 on ejaculate characteristics, serum antibody titers, viremia, and semen virus shedding.
Alberti KA; Estienne MJ; Meng XJ
J Anim Sci; 2011 May; 89(5):1581-7. PubMed ID: 21169515
[TBL] [Abstract][Full Text] [Related]
12. Influence of maternal antibodies on efficacy of porcine circovirus type 2 (PCV2) vaccination to protect pigs from experimental infection with PCV2.
Opriessnig T; Patterson AR; Elsener J; Meng XJ; Halbur PG
Clin Vaccine Immunol; 2008 Mar; 15(3):397-401. PubMed ID: 18094109
[TBL] [Abstract][Full Text] [Related]
13. Porcine circovirus type 2a or 2b based experimental vaccines provide protection against PCV2d/porcine parvovirus 2 co-challenge.
Opriessnig T; Karuppannan AK; Halbur PG; Calvert JG; Nitzel GP; Matzinger SR; Meng XJ
Vaccine; 2020 Feb; 38(8):1975-1981. PubMed ID: 31974016
[TBL] [Abstract][Full Text] [Related]
14. Comparison of three commercial one-dose porcine circovirus type 2 (PCV2) vaccines in a herd with concurrent circulation of PCV2b and mutant PCV2b.
Jeong J; Park C; Choi K; Chae C
Vet Microbiol; 2015 May; 177(1-2):43-52. PubMed ID: 25790733
[TBL] [Abstract][Full Text] [Related]
15. Effect of Maternal Antibody Transfer on Antibody Dynamics and Control of Porcine Circovirus Type 2 Infection in Offspring.
Dvorak CMT; Payne BJ; Seate JL; Murtaugh MP
Viral Immunol; 2018; 31(1):40-46. PubMed ID: 28817375
[TBL] [Abstract][Full Text] [Related]
16. PCV2 vaccination induces IFN-γ/TNF-α co-producing T cells with a potential role in protection.
Koinig HC; Talker SC; Stadler M; Ladinig A; Graage R; Ritzmann M; Hennig-Pauka I; Gerner W; Saalmüller A
Vet Res; 2015 Mar; 46():20. PubMed ID: 25888899
[TBL] [Abstract][Full Text] [Related]
17. One dose of a porcine circovirus 2 subunit vaccine induces humoral and cell-mediated immunity and protects against porcine circovirus-associated disease under field conditions.
Martelli P; Ferrari L; Morganti M; De Angelis E; Bonilauri P; Guazzetti S; Caleffi A; Borghetti P
Vet Microbiol; 2011 May; 149(3-4):339-51. PubMed ID: 21216540
[TBL] [Abstract][Full Text] [Related]
18. Efficacy of parenteral vaccination against porcine circovirus type 2 (PCV2) in seropositive piglets.
Gamage LN; McIntosh KA; Parker S; Harding J; Krakowka S; Ellis J
Can J Vet Res; 2012 Oct; 76(4):301-7. PubMed ID: 23543956
[TBL] [Abstract][Full Text] [Related]
19. Commercial PCV2a-based vaccines are effective in protecting naturally PCV2b-infected finisher pigs against experimental challenge with a 2012 mutant PCV2.
Opriessnig T; Gerber PF; Xiao CT; Halbur PG; Matzinger SR; Meng XJ
Vaccine; 2014 Jul; 32(34):4342-8. PubMed ID: 24929119
[TBL] [Abstract][Full Text] [Related]
20. A commercial porcine circovirus (PCV) type 2a-based vaccine reduces PCV2d viremia and shedding and prevents PCV2d transmission to naïve pigs under experimental conditions.
Opriessnig T; Xiao CT; Halbur PG; Gerber PF; Matzinger SR; Meng XJ
Vaccine; 2017 Jan; 35(2):248-254. PubMed ID: 27919634
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
